Polar Capital Global Healthcare Trust plc

Polar Capital Global Healthcare Trust plc

PCGH · LSE · Financial Services / Asset Management

469.00GBX-7.00 (-1.47%)

Price History

Full chart

Market Stats

Previous Close476.00
Open466.00
Day Range466.00 – 479.00
52-Week Range351.15 – 460.50
Volume265.18K
Market Cap460.41M
P/E (TTM)10.15
Forward P/E0.00
EPS0.42
Dividend Yield0.53%
Beta1.04
50-Day Avg443.35
200-Day Avg416.73

About

Polar Capital Global Healthcare Trust plc is a closed ended equity mutual fund launched and managed by Polar Capital LLP. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, with an emphasis on companies involved in pharmaceuticals, medical services, medical devices, and biotechnology. The fund primarily invests in dividend paying growth stocks of large-cap companies having a market capitalization greater than US $5 billion. It employs fundamental analysis with a bottom up stock picking approach to create its portfolio. The fund benchmarks the performance of its portfolio against the MSCI ACWI/Health Care Index. It was formerly known as Polar Capital Global Healthcare Growth and Income Trust plc. Polar Capital Global Healthcare Trust plc was formed on May 12, 2010 and is domiciled in the United Kingdom.

Company Details

Leadership

  • Ms. Tracey Anne Lago ACISCompany Secretary
  • Dr. Daniel Mahony Ph.D.Fund Manager
  • Mr. Gareth PowellFund Manager
  • Ms. Anna SizovaAnalyst
  • Mr. James Douglas Ph.D.Deputy Fund Manager
  • Mr. David Pinniger CFAFund Manager

Financials

Income Statement

Currency: GBP2010-09-302011-03-312011-09-302012-09-302013-09-302014-09-302015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302020-12-312021-09-302021-12-312022-09-302022-12-312023-09-302024-09-302025-09-30
Total Revenue6.80M6.80M8.48M24.21M29.51M33.03M17.40M43.82M4.30M51.32M-1.65M42.57M42.57M65.12M65.12M23.82M23.82M20.05M43.94M-26.63M
Growth (%)-0.00%+24.57%+185.64%+21.86%+11.93%-47.32%+151.87%-90.18%+1092.59%-103.21%+2687.78%0.00%+52.98%0.00%-63.43%0.00%-15.80%+119.09%-160.61%
Cost of Revenue-------1.89M2.23M2.47M2.82M3.00M-2.85M-3.09M-3.35M3.55M33.00K
Gross Profit6.80M6.80M8.48M24.21M29.51M33.03M17.40M43.82M2.07M48.85M-1.65M42.57M42.57M65.12M65.12M23.82M23.82M20.05M40.39M-26.66M
Gross Margin100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%48.15%95.19%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%91.91%100.12%
Operating Expense937.00K937.00K1.53M310.00K373.00K419.00K-11.43M472.00K-614.00K-708.00K1.68M1.82M1.82M1.68M1.68M1.75M1.75M1.85M-23.98M863.00K
Operating Income5.87M5.87M6.95M23.90M29.13M32.61M28.82M43.35M2.69M49.56M-3.33M40.74M40.74M63.44M63.44M22.07M22.07M18.21M64.36M-27.53M
Operating Margin86.23%86.23%81.96%98.72%98.74%98.73%165.69%98.92%62.42%96.57%202.13%95.72%95.72%97.42%97.42%92.65%92.65%90.80%146.48%103.36%
EBITDA5.87M5.87M3.66M23.90M29.13M10.68M17.47M43.35M2.69M49.56M-3.33M40.74M-63.44M-22.07M-18.21M64.36M-27.53M
EBITDA Margin86.23%86.23%43.13%98.72%98.74%32.34%100.44%98.92%62.42%96.57%202.13%95.72%-97.42%-92.65%-90.80%146.48%103.36%
Net Income5.56M5.56M6.45M23.43M28.63M32.05M16.28M42.66M1.96M49.12M-3.86M40.27M40.27M63.02M63.02M21.53M21.53M16.90M62.80M-28.05M
Net Income Margin81.69%81.69%76.03%96.77%97.02%97.04%93.59%97.35%45.64%95.71%234.65%94.61%94.61%96.77%96.77%90.40%90.40%84.25%142.93%105.34%
R&D-------6.910.682.30.491.31-1.29-1.94-0.77--
R&D as % of Total Revenue-------0.00%0.00%0.00%-0.00%0.00%-0.00%-0.00%-0.00%--
Interest Expense2.71M01.00K00011.88M06.00K14.00K45.00K7.00K7.00K2.00K2.00K2.00K2.00K44.00K68.00K33.00K
Interest Expense % of Total Revenue39.88%0.00%0.01%0.00%0.00%0.00%68.29%0.00%0.14%0.03%-2.74%0.02%0.02%0.00%0.00%0.01%0.01%0.22%0.15%-0.12%

Balance Sheet

Currency: GBP2010-09-302011-03-312011-09-302012-09-302013-09-302014-09-302015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302020-12-312021-09-302021-12-312022-09-302022-12-312023-09-302024-09-302025-09-30
Total Assets95.01M95.01M100.80M121.06M159.49M200.49M210.92M254.69M284.77M335.19M333.79M363.92M363.92M425.15M425.15M442.86M442.86M464.12M484.71M457.51M
Total Liabilities-855.00K374.00K318.00K3.74M534.00K480.00K6.86M34.64M38.92M45.34M38.79M3.38M39.42M2.96M38.03M38.03M44.94M5.64M9.40M
Total Equity24.55M24.55M100.42M120.74M155.75M199.96M210.44M247.82M250.13M296.26M288.45M325.13M325.13M385.73M385.73M404.83M404.83M419.18M479.07M448.11M
Cash2.90M2.90M6.84M112.00K844.00K13.00K1.95M7.37M856.00K13.85M6.86M17.84M17.84M13.72M13.72M7.55M7.55M4.68M9.55M17.04M
Total Debt---27.00K-110.00K274.00K10.00K25.00K1.71M4.00K35.41M-36.47M-37.56M-40.70M374.00K1.00K
Net Debt-2.90M-2.90M-6.84M-85.00K-844.00K97.00K-1.68M-7.36M-831.00K-12.14M-6.86M17.56M-17.84M22.75M-13.72M30.02M-7.55M-2.67M-9.18M-17.03M

Cash Flow

Currency: GBP2012-09-302013-09-302014-09-302015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302020-12-312021-09-302021-12-312022-09-302022-12-312023-09-302024-09-302025-09-30
Operating Cash Flow-3.64M-5.62M-13.10M7.58M10.95M-38.99M14.30M-1.28M14.58M14.58M-1.70M-1.70M-3.74M-3.74M-2.29M30.00K-1.43M
Investing Cash Flow----7.20M-40.31M13.69M-2.06M15.54M--1.05M--3.42M--1.01M48.91M12.20M
Financing Cash Flow-3.17M6.38M12.16M-5.80M-5.27M32.46M-3.00M-4.00M-3.59M-3.59M-2.43M-2.43M-2.43M-2.43M-2.59M-42.49M-2.91M
Capital Expenditure00000000000000000
Free Cash Flow-3.64M-5.62M-13.10M7.58M10.95M-38.99M14.30M-1.28M14.58M14.58M-1.70M-1.70M-3.74M-3.74M-2.29M49.01M-1.43M
Dividends Paid-3.41M4.11M4.36M4.76M3.79M2.45M2.44M2.55M2.55M2.43M2.43M2.43M2.43M2.55M2.91M2.91M
FCF to OCF100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%163350.00%100.00%
Dividend Paid to FCF--60.70%-31.34%57.53%43.50%-9.73%17.15%-190.86%17.47%17.47%-142.79%-142.79%-64.80%-64.80%-111.27%5.94%-203.64%

Earnings

Report DateMay 10, 2016Dec 22, 2016May 5, 2017Jan 26, 2018May 30, 2018Dec 19, 2018May 10, 2019Dec 19, 2019May 18, 2020Dec 15, 2020May 11, 2021Dec 17, 2021May 10, 2022Dec 12, 2022May 12, 2023
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.00----
EPS Actual0.010.340.08-0.06-0.080.50-0.070.04-0.140.470.100.420.160.020.07
Surprise---------------
Timing-----------Pre-marketPre-marketPre-marketAfter-hours

Key Statistics & Ratios

Market Cap460.41M
Enterprise Value0
Trailing P/E10.15
Forward P/E0.00
Price / Sales10.31
Price / Book1.27
EPS0.42
Revenue (TTM)0
Gross Profit (TTM)0
Profit Margin0.00%
Operating Margin0.00%
Return on Equity1773.09%
Return on Assets0.00%
Shares Outstanding103.00M
Shares Float0
Beta1.04
Dividend Yield0.53%
Dividend Rate0.02
Payout Ratio0.00%

Dividends

20262×
0.01Aug 6, 20260.01Feb 5, 2026
20252×
0.01Aug 7, 20250.01Feb 6, 2025
20242×
0.01Aug 1, 20240.01Feb 1, 2024
20232×
0.01Aug 3, 20230.01Feb 2, 2023
20222×
0.01Aug 4, 20220.01Feb 3, 2022
20212×
0.01Aug 5, 20210.01Feb 4, 2021
20202×
0.01Aug 6, 20200.01Feb 6, 2020
20192×
0.01Aug 1, 20190.01Feb 7, 2019
20182×
0.01Jul 26, 20180.01Feb 1, 2018
20172×
0.02May 18, 20170.01Feb 9, 2017
20164×
0.01Nov 3, 20160.02Jul 28, 20160.01May 19, 20160.01Feb 4, 2016